InvestorsHub Logo
Followers 25
Posts 2553
Boards Moderated 0
Alias Born 05/06/2009

Re: None

Sunday, 02/11/2018 1:29:52 PM

Sunday, February 11, 2018 1:29:52 PM

Post# of 46578
FRom a FAQ for Entramed when they did a reverse stock split...so if it goes this way, that is much better, but I would love to see what the actual contracts say for those warrants.
SO I read this and feel better about it it all, but still annoyed.
And want to read the exact wording and the way it is all spelled out, not some generic press release saying they are doing it.

https://us.astfinancial.com/Content/corporateaction/Files/CA08258_Entremed%20FAQS.pdf


Question 10. What is the impact of the reverse stock split on stock options and
warrants?
Answer. An adjustment will be made to the Company’s stock options and warrants based on
the split ratio. Warrant holders do not need to submit their warrants for exchange. The
adjustment will be made automatically. The number of shares of common stock issued subject
to stock options, warrants, or convertible securities will automatically be proportionately
decreased by the split ratio and the exercise price or conversion ratio will automatically be
proportionately increased by the same split ratio. For illustrative purposes, an option to
purchase 300,000 shares at an exercise price of $0.40 per share outstanding before the reverse
stock split will become, after a reverse split of 11, an option to purchase 27,273 shares at an
exercise price of $4.40. Options previously granted to management and employees will be
adjusted in the same manner as described above.
Question 11. What is the impact of the reverse stock split on the number of authorized
shares of common stock?
Answer. The number of authorized shares of common stock will remain the same. Having
additional authorized shares gives the Company a valuable tool to raise money to finance the
Company’s growth. We are pursuing and funding our ENMD-2076 Phase 2 ovarian cancer
clinical trial. We would consider expanding the ENMD-2076 program to additional trials and
indications if we conclude that they would benefit the Company and its shareholders. To do so,
we would need to raise additional financing. The availability of the authorized shares provides
us the flexibility to raise the additional capital if needed.